Skip to main content

West Pharmaceutical Services Value Stock - Dividend - Research Selection

West pharmaceutical services

ISIN: US9553061055 , WKN: 864330

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


West to Host First-Quarter 2026 Conference Call

2026-04-09
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2026 financial results before the market opens on Thursday, April 23, 2026, and will follow with a conference call to discuss the results and business expectations at 8:00 a.m. Eastern Time.

Down 30% This Year: Analysts Say These 2 Beaten-Down Stocks Are Poised to Rebound

2026-04-09
‘Buy low and sell high’ is one of the most basic principles in investing, and it tends to stand out when fundamentally sound stocks trade at depressed levels. In many cases, those lower prices are exactly what create the opportunity. A declining share price doesn’t automatically mean the business is broken – the pressure may stem from issues that are temporary or fixable rather than structural. When the underlying fundamentals remain intact, analysts are often quick to flag the disconnect, givin

Top 50 High-Quality Dividend Growth Stocks For April 2026

2026-04-07
I track a universe of 50 high-quality dividend growth stocks to identify attractive entry points based on updated valuations and forward return estimates.

ALGN vs. WST: Which Stock Should Value Investors Buy Now?

2026-04-06
ALGN vs. WST: Which Stock Is the Better Value Option?

Does Dublin Automation Expansion Reshape the Bull Case for West Pharmaceutical Services’ Injectable Platform (WST)?

2026-04-04
In March 2026, West Pharmaceutical Services opened a 165,000-square-foot expansion at its Damastown, Dublin site, adding advanced automation and commercial-scale drug-handling capabilities to serve high-volume injectable therapies, including treatments for diabetes and obesity. This build-out deepens the West Vantage contract services platform, positioning West as a single-source partner from drug-device design through commercial manufacturing and regulatory support for injectable...

Is It Too Late To Reconsider West Pharmaceutical Services (WST) After Its Recent Share Price Rebound?

2026-04-03
If you are wondering whether West Pharmaceutical Services is priced fairly or if the current share price is leaving value on the table, this article walks through key signals to help you frame that question clearly. The stock last closed at US$254.80, with returns of 2.7% over 7 days, 1.4% over 30 days, a 7.8% decline year to date, 16.2% over 1 year, a 25.5% decline over 3 years and an 11.6% decline over 5 years. This gives you a mixed picture of how the market has treated the shares across...

Wingstop upgraded, Wix downgraded: Wall Street’s top analyst calls

2026-04-03
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly.End of Quarter Sale - 50% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Top 5 Upgrades: Erste Group upgraded Walmart (WMT) to Buy from Hold. Increased sales a

WST Expands Dublin Facility to Boost Injectable Therapy Capacity

2026-04-01
West Pharmaceutical expands Dublin facility to boost injectable therapy capacity and strengthen its end-to-end manufacturing platform.

The Old Market Playbook Is Breaking - This Is The Strategy I'm Betting On

2026-04-01
Shift capital to scarcity-driven assets—energy, metals, infrastructure, and defense—using the TOLL framework. Read more macro analysis here.

West Pharmaceutical Services Inc. stock rises Tuesday, still underperforms market

2026-03-31
West Pharmaceutical Services Inc. stock rises Tuesday, still underperforms market